The Paris System for Urine Cytology: Prospective Assessment of Reproducibility, Diagnostic Accuracy, and Malignancy Risk
Diagnostic Cytopathology · 2026-07 · 54 (7) · 506-518
DOI: 10.1002/dc.70128 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diagnostic Cytopathology, online erschienen am 23.04.2026. Verfasst von Ankit Gupta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Urine, Cytodiagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Urine cytology is widely used for the detection and surveillance of urothelial carcinoma but has historically suffered from variability in interpretation. The Paris System for Reporting Urinary Cytology (TPS) was developed to standardize reporting and improve clinical relevance by focusing on high‐grade urothelial carcinoma (HGUC).
Methods
This prospective observational study included 170 urine samples from patients clinically suspected of urothelial neoplasia. Cytology smears were independently evaluated by two experienced cytopathologists and categorized according to TPS. Suspicious for HGUC (SHGUC) and HGUC were considered cytology‐positive. Histopathology (transurethral resection of bladder tumor) served as the reference standard where available; radiologic findings with clinical follow‐up were used otherwise. Interobserver agreement, diagnostic performance, and risk of high‐grade malignancy (ROHM) for each TPS category were calculated with 95% confidence intervals.
Results
Interobserver agreement was excellent across TPS categories (κ = 0.985, p < 0.001) and perfect after binary classification (κ = 1.000). Using the SHGUC threshold, urine cytology demonstrated high diagnostic accuracy against the combined reference standard, with sensitivity of 92.86% (95% CI, 80.99–97.54), specificity of 100% (95% CI, 97.09–100.0), and overall accuracy of 98.24% (95% CI, 94.94–99.40). ROM was 100.0% for both SHGUC and HGUC, 57.1% for atypical urothelial cells, and 0.8% for negative for HGUC. Haematuria, male sex, and increasing age were significantly associated with malignancy.
Conclusions
TPS provides highly reproducible, clinically meaningful urine cytology reporting with excellent specificity and strong sensitivity for HGUC. ROM stratification reinforces the clinical utility of SHGUC and HGUC categories and supports integrated interpretation of cytology with clinical and radiologic findings in routine practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
- Departent of Urology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
ORCID-Profile: Ankit Gupta, Subrat Chandra, Tripti Verma, Anurag Gupta, Pradyumn Singh, Ishwar Ram Dhayal, Alok Srivastava
Zitieren
APA
Gupta, A., Chandra, S., Verma, T., Gupta, A., Singh, P., Dhayal, I. R., & Srivastava, A. (2026). The Paris System for Urine Cytology: Prospective Assessment of Reproducibility, Diagnostic Accuracy, and Malignancy Risk. Diagnostic Cytopathology, 54(7), 506-518. https://doi.org/10.1002/dc.70128
Vancouver
Gupta A, Chandra S, Verma T, Gupta A, Singh P, Dhayal IR, et al. The Paris System for Urine Cytology: Prospective Assessment of Reproducibility, Diagnostic Accuracy, and Malignancy Risk. Diagnostic Cytopathology. 2026;54(7):506-518. doi:10.1002/dc.70128
BibTeX
@article{Gupta2026,
author = {Gupta, Ankit and Chandra, Subrat and Verma, Tripti and Gupta, Anurag and Singh, Pradyumn and Dhayal, Ishwar Ram and Srivastava, Alok},
title = {The Paris System for Urine Cytology: Prospective Assessment of Reproducibility, Diagnostic Accuracy, and Malignancy Risk},
journal = {Diagnostic Cytopathology},
year = {2026},
volume = {54},
number = {7},
pages = {506--518},
doi = {10.1002/dc.70128}
}
EUVIMED